Integer Holdings Corporation (ITGR)

Market Cap	2.75B
Revenue (ttm)	1.83B
Net Income (ttm)	86.90M
Shares Out	35.04M
EPS (ttm)	2.42
PE Ratio	32.24
Forward PE	12.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	433,959
Open	77.98
Previous Close	78.34
Day's Range	77.88 - 78.89
52-Week Range	62.00 - 146.36
Beta	0.81
Analysts	Buy
Price Target	95.00 (+21.13%)
Earnings Date	Feb 19, 2026

About ITGR

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable c...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 29, 2000
• Employees: 11,000
• Stock Exchange: NYSE
• Ticker Symbol: ITGR
• Website: https://www.integer.net

Financial Performance

In 2024, Integer Holdings's revenue was $1.72 billion, an increase of 10.35% compared to the previous year's $1.56 billion. Earnings were $119.90 million, an increase of 32.26%.

Analyst Summary

According to 8 analysts, the average rating for ITGR stock is "Buy." The 12-month stock price target is $95.0, which is an increase of 21.13% from the latest price.

Price Target

$95.0

(21.13% upside)

Analyst Consensus: Buy